Overview
- A hot-mic exchange in Beijing captured Vladimir Putin touting repeated organ transplants and lifespans up to 150 years, with the clip later removed from the web reportedly at China’s request.
- Investigations show Russian public support for life‑extension projects jumped from seven initiatives in 2016–2022 to 43 in the past three years, with allocations rising from 20 million to 172 million rubles.
- The leading program is directed by endocrinologist Maria Vorontsova, identified as Putin’s daughter, who also controls Nomeko and recently acquired clinics and research centers from Gazprom’s pension fund.
- Vorontsova sits on the board of a 127‑billion‑ruble national genetics effort chaired by Putin ally Mikhail Kovalchuk, as the Russian Science Foundation increases grants for aging research.
- The funding push contrasts with Russia’s male life expectancy of about 68 years and comes as global longevity science advances yet faces scale, cost and equity concerns.